Empfehlungen für die Umgebungsuntersuchungen bei Tuberkulose – Update 2023
Standard
Empfehlungen für die Umgebungsuntersuchungen bei Tuberkulose – Update 2023. / Diel, Roland; Breuer, Cornelia; Bös, Lena; Geerdes-Fenge, Hilte; Günther, Annette; Häcker, Brit; Hannemann, Jörg; Nienhaus, Albert; Priwitzer, Martin; Witte, Peter; Bauer, Torsten.
In: GESUNDHEITSWESEN, Vol. 85, No. 11, 11.2023, p. 1076-1098.Research output: SCORING: Contribution to journal › Guideline, recommendation, statement › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Empfehlungen für die Umgebungsuntersuchungen bei Tuberkulose – Update 2023
AU - Diel, Roland
AU - Breuer, Cornelia
AU - Bös, Lena
AU - Geerdes-Fenge, Hilte
AU - Günther, Annette
AU - Häcker, Brit
AU - Hannemann, Jörg
AU - Nienhaus, Albert
AU - Priwitzer, Martin
AU - Witte, Peter
AU - Bauer, Torsten
N1 - Thieme. All rights reserved.
PY - 2023/11
Y1 - 2023/11
N2 - The aim of contact tracing for tuberculosis is in addition to active case finding the detection of chains of infection and the prevention of the further spread of the disease. In this context, a careful selection of contact persons is necessary, depending on the type and duration of contact, to identify persons who are recently infected and therefore to increase the benefit of a preventive therapy and to avoid unnecessary testing of persons who are not at risk of infection. Since the last update of the recommendations on contact tracing, data on the use of interferon-y release assays (IGRAs) in children has been improved markedly. These are the preferred test in contact tracing of adults. For children, both IGRAs and the tuberculin skin test can be used equivalently. Rifampicin for 4 months, rifampicin and isoniazid for 3 months, or isoniazid for 9 months are recommended as preventive therapy in cases of confirmed infection.The implementation of the contact tracing in different age groups as well as legal framework conditions and socio-medical aspects and challenges are dealt with in detail. In addition, special cases, such as environmental screening in day-care centers, schools, or other community facilities, are discussed separately.
AB - The aim of contact tracing for tuberculosis is in addition to active case finding the detection of chains of infection and the prevention of the further spread of the disease. In this context, a careful selection of contact persons is necessary, depending on the type and duration of contact, to identify persons who are recently infected and therefore to increase the benefit of a preventive therapy and to avoid unnecessary testing of persons who are not at risk of infection. Since the last update of the recommendations on contact tracing, data on the use of interferon-y release assays (IGRAs) in children has been improved markedly. These are the preferred test in contact tracing of adults. For children, both IGRAs and the tuberculin skin test can be used equivalently. Rifampicin for 4 months, rifampicin and isoniazid for 3 months, or isoniazid for 9 months are recommended as preventive therapy in cases of confirmed infection.The implementation of the contact tracing in different age groups as well as legal framework conditions and socio-medical aspects and challenges are dealt with in detail. In addition, special cases, such as environmental screening in day-care centers, schools, or other community facilities, are discussed separately.
KW - Child
KW - Adult
KW - Humans
KW - Isoniazid/therapeutic use
KW - Contact Tracing
KW - Rifampin
KW - Germany
KW - Tuberculosis/diagnosis
U2 - 10.1055/a-2148-7769
DO - 10.1055/a-2148-7769
M3 - Leitlinie, Empfehlung, Stellungnahme
C2 - 37972583
VL - 85
SP - 1076
EP - 1098
JO - GESUNDHEITSWESEN
JF - GESUNDHEITSWESEN
SN - 0941-3790
IS - 11
ER -
